Hire Fractional CTO for Biotech Startups
Senior, direct, no layers

A biotech startup runs on experiments, data, and milestones: assays to validate, CRO studies to oversee, investor updates to write, and a regulatory path that must be documented from the earliest work. Data scattered across notebooks and inboxes slows every one of those.

The value is not advice from the sidelines. It is ownership: a technology roadmap the organization can afford, vendors held to account, and a team that knows what to build next and why.

Picture a CRO dataset arriving in a format nobody can use, days before an investor update is due. In that situation, a CTO-level decision about which system to fix, which vendor to hold to account, and what to build next would cut through months of drift. Book a free discovery call and we will test the fit on one real workflow before any wider scope is agreed.

an electronic lab notebook such as Benchling, a LIMS, bioinformatics pipelines, and CRO data portals already cover much of the work at biotech startups. What is usually missing is the routine around them: consistent handoffs, visible status, and checks that catch errors before they reach research partners, investors, and CRO teams.

The leadership work spans an electronic lab notebook such as Benchling and a LIMS and every vendor around them, with the audit naming which tools serve the organization and which merely cost it money. No vendor relationship is taken as given.

This page describes services, not scientific or regulatory advice. Research and regulatory decisions stay with the startup's qualified scientific staff. FDA IND and BLA pathways shapes what can be automated or changed, and the work is scoped to fit it rather than work around it.

For a startup like this, success looks like scientists spending time on science, partners getting clean data, and milestones documented well enough to survive diligence.

Two problems deserve naming: experimental data scattered across notebooks and drives and CRO results arriving late or in unusable formats. Both persist when the underlying routine stays manual and nobody owns the follow-up, so each deliverable in this engagement is paired with a named owner and a visible queue, and problems surface while they are still small.

What changes is direction: technology stops being a list of purchases and becomes a sequenced plan the leadership understands and the team can execute.

Browse all hire engagements or discuss your biotech startup workflow directly.